Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.61 |
| ▸ | MAOA | P21397 | 12/20 | 0.59 |
| ▸ | MAOB | P27338 | 12/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.51 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4207969 | 0.94 | MAPT (0.59) | XDHMAOAMAOBKDM4ENPC1 | |
| SCHEMBL1796580 | 0.94 | XDH (0.57) | XDHMAOAMAOBKDM4ENPC1 | |
| Hydrochloric Acid SCHEMBL4213278 | 0.93 | MAPT (0.58) | XDHMAOAMAOBKDM4ENPC1 | |
| SCHEMBL12795338 | 0.92 | MAOA (0.56) | XDHMAOAMAOBKDM4ENPC1 | |
| SCHEMBL1796441 | 0.91 | XDH (0.56) | XDHMAOAMAOBKDM4ENPC1 | |
| SCHEMBL21084279 | 0.88 | MAOB (0.53) | XDHMAOAMAOBKDM4ENPC1 | |
| SCHEMBL20124806 | 0.88 | MAOA (0.55) | XDHMAOAMAOBKDM4ENPC1 | |
| SCHEMBL12795334 | 0.87 | MAOA (0.50) | XDHMAOAMAOBKDM4ENPC1 | |
| SCHEMBL1794894 | 0.87 | MAPT (0.57) | XDHMAOBMAPTSIGMAR1ALK | |
| SCHEMBL1794732 | 0.86 | XDH (0.60) | XDHMAOAMAOBKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7740482-B2 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | BLUESTAR SILICONES FRANCE (FR) | 2010-06-22 | — | — | US | claimed |
| EP-1745083-B1 | HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION | BLUESTAR SILICONES FRANCE (FR) | 2009-12-16 | — | — | EP | claimed |
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2008-11-20 | — | — | US | claimed |
| EP-1745083-A1 | HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION | Rhodia Chimie (FR) | 2007-01-24 | — | — | EP | claimed |
| WO-2005121200-A1 | HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION | RHODIA CHIMIE (FR) | 2005-12-22 | — | — | WO | claimed |
| US-20050261390-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2005-11-24 | — | — | US | claimed |
| US-8916624-B2 | Dental compositions crosslinkable/polymerizable by cationic process | BLUESTAR SILICONES FRANCE SAS (FR) | 2014-12-23 | — | — | US | disclosed |
| US-8227047-B2 | Radiation curable inkjet fluids and inks improved for photoyellowing | AGFA GRAPHICS NV (BE) | 2012-07-24 | — | — | US | disclosed |
| US-8227047-B2 | Radiation curable inkjet fluids and inks improved for photoyellowing | AGFA GRAPHICS NV (BE) | 2012-07-24 | — | — | US | disclosed |
| US-20110189632-A1 | DENTAL COMPOSITIONS CROSSLINKABLE/POLYMERIZABLE BY CATIONIC PROCESS | BLUESTAR SILICONES FRANCE (FR) | 2011-08-04 | — | — | US | disclosed |
| US-20100330296-A1 | RADIATION CURABLE INKJET FLUIDS AND INKS IMPROVED FOR PHOTOYELLOWING | AGFA GRAPHICS NV (BE) | 2010-12-30 | — | — | US | disclosed |
| US-20100330296-A1 | RADIATION CURABLE INKJET FLUIDS AND INKS IMPROVED FOR PHOTOYELLOWING | AGFA GRAPHICS NV (BE) | 2010-12-30 | — | — | US | disclosed |
| US-7740482-B2 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | BLUESTAR SILICONES FRANCE (FR) | 2010-06-22 | — | — | US | disclosed |
| EP-2053102-A1 | Radiation curable inkjet fluids and inks improved for photoyellowing | Agfa Graphics N.V. (BE) | 2009-04-29 | — | — | EP | disclosed |
| EP-2043588-A2 | DENTAL COMPOSITION CROSSLINKABLE/POLYMERIZABLE BY CATIONIC PROCESS | Bluestar Silicones France (FR) | 2009-04-08 | — | — | EP | disclosed |
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2008-11-20 | — | — | US | disclosed |
| WO-2008009718-A2 | DENTAL COMPOSITION CROSSLINKABLE/POLYMERIZABLE BY CATIONIC PROCESS | BLUESTAR SILICONES FRANCE (FR) | 2008-01-24 | — | — | WO | disclosed |
| EP-1745083-A1 | HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION | Rhodia Chimie (FR) | 2007-01-24 | — | — | EP | disclosed |
| WO-2005121200-A1 | HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION | RHODIA CHIMIE (FR) | 2005-12-22 | — | — | WO | disclosed |
| US-20050261390-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RFC1, RFC2, HNRNPC | XDH 3244/4885MAOA 1576/4885MAOB 710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.